BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Della Corte C, Aghemo A, Colombo M. Individualized hepatocellular carcinoma risk: The challenges for designing successful chemoprevention strategies. World J Gastroenterol 2013; 19(9): 1359-1371 [PMID: 23538741 DOI: 10.3748/wjg.v19.i9.1359]
URL: https://www.wjgnet.com/1948-0210/full/v19/i9/1359.htm
Number Citing Articles
1
Pierre Nahon, Jean‐Charles Nault. Constitutional and functional genetics of human alcohol‐related hepatocellular carcinomaLiver International 2017; 37(11): 1591 doi: 10.1111/liv.13419
2
Meral Tuncbilek, Aslıgul Kucukdumlu, Ebru Bilget Guven, Duygu Altiparmak, Rengul Cetin-Atalay. Synthesis of novel 6-substituted amino-9-(β-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cellsBioorganic & Medicinal Chemistry Letters 2018; 28(3): 235 doi: 10.1016/j.bmcl.2017.12.070
3
Ding Shen, Jie Zheng, Xiping Cui, Yingshan Chen, Qiyi He, Rui Lv, Zhaoxia Li, Suqing Zhao. Analysis of cholyglycine acid as a biomarker for the early diagnosis of liver disease by fluorescence polarization immunoassaySensors and Actuators B: Chemical 2018; 256: 846 doi: 10.1016/j.snb.2017.10.013
4
Adriano M. Pellicelli, Pascal Vignally, Vincenzo Messina, Antonio Izzi, Ettore Mazzoni, Angelo Barlattani, Donato Bacca, Mario Romano, Fabrizio Mecenate, Tommaso Stroffolini, Caterina Furlan, Antonio Picardi, Umberto V. Gentilucci, Roberto Gulminetti, Maria E. Bonaventura, Roberto Villani, Cecilia D’Ambrosio, Amerigo Paffetti, Cristina Mastropietro, Massimo Marignani, Lucia Fondacaro, Giuseppe Cerasari, Arnaldo Andreoli, Giorgio Barbarini. Long term nucleotide and nucleoside analogs treatment in chronic hepatitis B HBeAg negative genotype D patients and risk for hepatocellular carcinomaAnnals of Hepatology 2014; 13(4): 376 doi: 10.1016/S1665-2681(19)30844-0
5
N. G. Danilenko, M. G. Siniauskaya, S. P. Lukashyk, I. A. Karpov, O. G. Davydenko. “Double Punch”: Hepatitis C in Patients with Genetic Defects of Iron MetabolismCytology and Genetics 2019; 53(5): 407 doi: 10.3103/S0095452719050062
6
Wan-Xia Yang, Yun-Yan Pan, Chong-Ge You. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic AnalysisBioMed Research International 2019; 2019: 1 doi: 10.1155/2019/1245072
7
Brian I. Carr, Petr Pancoska, Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Gian Ludovico Rapaccini, Maria Di Marco, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani. Identification of Two Clinical Hepatocellular Carcinoma Patient Phenotypes From Results of Standard Screening ParametersSeminars in Oncology 2014; 41(3): 406 doi: 10.1053/j.seminoncol.2014.04.002
8
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapiesMolecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
9
Min Qi, Yu Chen, Guo-Qiang Zhang, Yu-Juan Meng, Fu-Li Zhao, Jing Wang, Jun Ma. Clinical significance of preoperative liver stiffness measurements in primary HBV-positive hepatocellular carcinomaFuture Oncology 2017; 13(30): 2799 doi: 10.2217/fon-2017-0281
10
Bendong Chen, Wenyan Zhou, Chaofeng Tang, Genwang Wang, Peng Yuan, Yawen Zhang, Sah Chandra Bhushan, Jinlong Ma, Junzhi Leng. Down-Regulation of C3aR/C5aR Inhibits Cell Proliferation and EMT in Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2020; 19: 153303382097066 doi: 10.1177/1533033820970668
11
Pierre Nahon, Angela Sutton, Marianne Ziol, Jessica Zucman-Rossi, Jean-Claude Trinchet, Nathalie Ganne-Carrié. Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver diseaseHepatic Oncology 2015; 2(1): 63 doi: 10.2217/hep.14.26
12
Maciej Adler, Licia Larocca, Francesca M. Trovato, Heather Marcinkowski, Yasmin Pasha, Simon D. Taylor-Robinson. Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre studyHPB 2016; 18(8): 678 doi: 10.1016/j.hpb.2016.05.005
13
Kaku Goto, Naoya Kato. MICA SNPs and the NKG2D system in virus-induced HCCJournal of Gastroenterology 2015; 50(3): 261 doi: 10.1007/s00535-014-1000-9